2026 Cardiovascular-Kidney-Metabolic Syndrome Guideline
In this video, Writing Committee Chair Chiadi E. Ndumele, MD, PhD, MHS, FAHA and Vice Chair Fatima Rodriguez, MD, MPH, FAHA, FACC discuss the growing clinical and public health burden of cardiovascular-kidney-metabolic (CKM) syndrome, highlighting the interconnected roles of obesity, diabetes, chronic kidney disease, and cardiovascular disease. They outline the guideline’s goal to provide a unified, evidence-based framework across specialties, emphasizing earlier risk detection (including PREVENT equations), CKM staging across the life course, and routine assessment of metabolic and kidney health.
